Gene mutation increases thromboembolism risk in women taking tamoxifen

Women taking tamoxifen for early-stage breast cancer who developed blood clots were more likely to carry a gene mutation for clotting than women taking tamoxifen who did not develop blood clots, according to an online study published June 16 in The Journal of the National Cancer Institute.

Read the whole article on Physorg

More from Physorg